High AMH but Few Eggs Retrieved: Why IVF Response Can Surprise You

AMH reflects activity in small ovarian follicles and can help anticipate response to stimulation. It does not count eggs that are already waiting to be retrieved, and it is not a reliable stand-alone prediction of pregnancy. Antral follicle count and age provide additional context. Some patients have discordant AMH and ultrasound findings, and different assays can complicate comparisons. Ask the doctor what response range was anticipated before stimulation rather than judging treatment by a single number from an unrelated laboratory report.

A useful review includes starting dose, daily medications, follicle measurements across scans, hormone results when taken, duration of stimulation, and the reason for choosing the trigger day. Follicles on ultrasound do not all yield an egg; their size and maturity may vary. Ask how many follicles were considered likely to produce eggs, how many oocytes were collected and how many were mature. Those are different stages, and mixing them together can conceal where the unexpected loss occurred. A clinician should explain deviations from the original plan.

Egg maturation depends on a correctly planned trigger and retrieval interval. If a dose was missed, taken at the wrong time or not absorbed as expected, the team needs the actual history without blame. Rare technical and physiological reasons also exist for fewer eggs than follicles. The retrieval note may show whether one ovary was inaccessible or a procedure was shortened for safety. These possibilities should be assessed using records, not by assuming the next cycle needs more injections or an arbitrary add-on.

An individualised adjustment might involve closer monitoring, modified stimulation or different trigger planning, but a change is not automatically necessary after one unusual cycle. Age, polycystic ovary pattern, past responses, embryo results and the potential for overstimulation all influence choices. High AMH can coexist with increased OHSS risk in certain patients, so maximising egg number at any cost is not a safe goal. Discuss whether the previous count represents a genuinely poor response or simply an expectation that was too precise.

More eggs can create more opportunities, but the number retrieved is not the same as the number of mature eggs, normally fertilised eggs, embryos or live births. Ask for a stage-by-stage embryology report if fertilisation was attempted. If the concern involves laboratory practice, request a factual explanation of events and consent documentation. The goal of a second opinion is to identify a potentially correctable issue while acknowledging ordinary biological variation. It should end with a practical next-cycle plan and realistic uncertainty rather than an impossible egg-count guarantee.

The HomeIVF approach combines medical supervision with selected home-supported logistics rather than offering “DIY IVF.” Depending on local availability and the case, patients may discuss investigations by teleconsultation, eligible home blood draws, injection guidance or nursing support. These are aids to a doctor-led treatment plan, not replacements for required ultrasound imaging, physical examination, urgent assessment or laboratory procedures. Egg retrieval, embryo culture, ICSI and embryo transfer all need appropriate facilities. For complex diagnoses especially, convenience must never determine whether a medically necessary visit happens. A written plan should identify the responsible clinician, test-result turnaround process and circumstances requiring in-person review.

Create a simple table for each previous cycle: AMH and AFC, stimulation start dose, follicle count on trigger day, retrieval date, eggs obtained, mature eggs and embryos developed. If a value is missing, label it missing rather than estimating. This makes a second-opinion conversation much clearer. Ask whether the problem was fewer growing follicles, fewer eggs per mature follicle or a low proportion of mature eggs. These are different questions with different possible explanations. Also ask whether the change you are being offered has a proven advantage or is a reasonable but uncertain experiment in a subsequent cycle.

A safe plan should also be financially intelligible. Request a stage-by-stage quote, including medication changes, monitoring, specialist referral, anaesthesia or laboratory services if applicable, and what happens if a cycle cannot proceed. Confirm whether future frozen embryo transfers and storage are separate charges. A second opinion is not an obligation to buy another package; it should clarify decisions and help avoid tests or add-ons without a clear indication. If any provider promises a guaranteed result or insists on a deposit before explaining risks, ask for independent clinical advice.

The safest next step is an individualised review of the available records with a qualified fertility clinician and, when needed, a relevant specialist. Ask what is established, what remains uncertain and exactly how a proposed test or treatment would change care. The aim is informed progress, not a guaranteed outcome.